Effect of pioglitazone on decreasing of proteinuria in type 2 diabetic patients with nephropathy
ConclusionThe study showed that low dose of pioglitazone is an effective, safe and inexpensive method in reducing of proteinuria in type2 diabetic patients with nephropathy.
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Actos | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Metabolic Syndrome | Proteinuria | Study